Endocrine Society Meets with NIH Office of Research on Women’s Health to Discuss Research Gaps & Policy Priorities

On Thursday, December 1, Janine Austin Clayton, MD, director of the NIH Office of Research on Women’s Health (ORWH) and associate director of Women’s Health Research at the NIH visited the Endocrine Society for a meeting with Endocrine Society member and associate director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Jane Reusch, MD; and the director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Judy Regensteiner, PhD.

Participants in the Endocrine Society meeting with the NIH Office of Research on Women’s Health (ORWH) included Joseph M. Laakso, PhD, associate director, science policy, Endocrine Society;  Mila Becker, JD, chief policy officer, Endocrine Society; Jennifer Plank-Bazinet, PhD, research program officer, ORWH; Barbara Byrd Keenan, FASAE, CAE, CEO, Endocrine Society; Jane Reusch, MD, associate director, Center for Women's Health Research, professor of medicine, University of Colorado; Janine Austin Clayton, MD, director, ORWH and associate director for Women's Health Research, NIH; and Juliana M. Blome, PhD, MPH, associate director for science policy, planning, and analysis, ORWH.
Participants in the Endocrine Society meeting with the NIH Office of Research on Women’s Health (ORWH) included Joseph M. Laakso, PhD, associate director, science policy, Endocrine Society; Mila Becker, JD, chief policy officer, Endocrine Society; Jennifer Plank-Bazinet, PhD, research program officer, ORWH; Barbara Byrd Keenan, FASAE, CAE, CEO, Endocrine Society; Jane Reusch, MD, associate director, Center for Women’s Health Research, professor of medicine, University of Colorado; Janine Austin Clayton, MD, director, ORWH and associate director for Women’s Health Research, NIH; and Juliana M. Blome, PhD, MPH, associate director for science policy, planning, and analysis, ORWH.

During the meeting, participants discussed research gaps and opportunities identified during the National Conference on Women’s Health Research, “Sex Differences Across the Lifespan: A Focus on Metabolism” (recently highlighted in the July Endocrine News). The group also discussed the new NIH policy on the “Consideration of Sex as a Biological Variable in NIH-funded Research.” The meeting highlighted the many synergies between the policy priorities and research interests of ORWH and the Endocrine Society.

Several specific opportunities were identified during the meeting, including working together on developing educational resources about how to appropriately consider sex as a biological variable and promoting existing resources such as the online developed by ORWH.

You may also like

  • Endocrine Society Advocacy Update – March 2024

    Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before…

  • Advocacy Update: February 2024

    Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs…

Find more in